In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned committee:
Times and Dates: 8:30 a.m.-5:00 p.m., EDT, May 3, 2017; 8:30 a.m.-12:00 p.m., EDT, May 4, 2017.
Place: CDC, Global Communications Center, 1600 Clifton Road NE., Building 19, Auditorium B3, Atlanta, Georgia 30329.
Status: The meeting is open to the public, limited only by the space available. The meeting room will accommodate up to 100 people.
Purpose: The BSC, OID, provides advice and guidance to the Secretary, Department of Health and Human Services; the Director, CDC; the Director, OID; and the Directors of the National Center for Immunization and Respiratory Diseases, the National Center for Emerging and Zoonotic Infectious Diseases, and the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC, in the following areas: Strategies, goals, and priorities for programs; research within the national centers; and overall strategic direction and focus of OID and the national centers.
Matters for Discussion: The meeting will include updates from CDC's infectious disease national centers; reports from the BSC's Food Safety Modernization Act Surveillance Working Group and Infectious Disease Laboratory Working Group; and focused discussions on priority emerging infectious diseases including antimicrobial resistance, influenza, and selected zoonotic and vector-borne diseases.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Robin Moseley, M.A.T., Designated Federal Officer, OID, CDC, 1600 Clifton Start Printed Page 17667Road NE., Mailstop D10, Atlanta, Georgia 30329, Telephone: (404) 639-4461.
The Director, Management Analysis and Services Office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.
Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.
[FR Doc. 2017-07323 Filed 4-11-17; 8:45 am]
BILLING CODE 4163-18-P